Transactivation of the CCL5/RANTES gene by Epstein-Barr virus latent membrane protein 1. (Q40479008)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

20 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Transactivation of the CCL5/RANTES gene by Epstein-Barr virus latent membrane protein 1. (English)

1 reference

20 September 2017

0 references

1 reference

Jun-Nosuke Uchihara

1

1 reference

20 September 2017

Alan M Krensky

2

1 reference

20 September 2017

Takehiro Matsuda

3

1 reference

20 September 2017

Hirochika Kawakami

4

1 reference

20 September 2017

Taeko Okudaira

5

1 reference

20 September 2017

Masato Masuda

6

1 reference

20 September 2017

Takao Ohta

7

1 reference

20 September 2017

Nobuyuki Takasu

8

1 reference

20 September 2017

Naoki Mori

9

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

International Journal of Cancer

20 September 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

20 September 2017

volume

114

1 reference

20 September 2017

issue

5

1 reference

20 September 2017

page(s)

747-755

1 reference

Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism

20 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FIJC.20784

Abundant expression of chemokines in malignant and infective human lymphadenopathies.

21 January 2018

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Chemokines and leukocyte traffic

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

30 December 2023

Chemokines in immunity

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

RANTES Production by Memory Phenotype T Cells Is Controlled by a Posttranscriptional, TCR-Dependent Process

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Chemokines and their role in tumor growth and metastasis

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

T-cell subsets: chemokine receptors guide the way.

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Constitutive expression of various chemokine genes in human T-cell lines infected with human T-cell leukemia virus type 1: role of the viral transactivator Tax.

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-kappaB activation

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Chemokines, lymphocytes and viruses: what goes around, comes around

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Early responses to infection: chemokines as mediators of inflammation

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Kinetics of transcription factors regulating the RANTES chemokine gene reveal a developmental switch in nuclear events during T-lymphocyte maturation

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Transcriptional regulation of RANTES expression in T lymphocytes

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Epstein-Barr virus latent membrane protein-1 induction by histone deacetylase inhibitors mediates induction of intercellular adhesion molecule-1 expression and homotypic aggregation

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Bridging the gap: composition, regulation, and physiological function of the IkappaB kinase complex

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Human chemokines: an update

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

MEKK1 activates both IkappaB kinase alpha and IkappaB kinase beta

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

RANTES chemokine expression in diseased and normal human tissues

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

RFLAT-1: a new zinc finger transcription factor that activates RANTES gene expression in T lymphocytes

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Human T-cell leukemia virus type 1 Tax induction of NF-kappaB involves activation of the IkappaB kinase alpha (IKKalpha) and IKKbeta cellular kinases

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Histone acetylation and reactivation of Epstein-Barr virus from latency.

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

Epstein-Barr virus genomic sequences and specific antibodies in cerebrospinal fluid in children with neurologic complications of acute and reactivated EBV infections

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

A translational rheostat for RFLAT-1 regulates RANTES expression in T lymphocytes

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1002/IJC.20784

30 December 2023

Identifiers

DOI

10.1002/IJC.20784

1 reference

20 September 2017

1 reference